Altmetric – Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PREVENTED COVID. •https://t.co/RhsS2M2FZj

23 Feb 2023

@Phoenix_Timber @TattyToque @DFisman Where’s the “eight mice” garbage coming from ?? Both bivalent booster were tested on over 360,000 people ……. and shown to be much more effective than the ancestral monovalent vaccine https://t.co/nI0lABQYuU

19 Feb 2023

@famulare_mike @gerrythek @ENirenberg Do we have a good sense of how strong? I thought that variant mismatch and the vaccines being systemic immunization also worked against VE vs infection. E.g. Table 2 (aVE) doesn't look high (even if rVE is significant)

16 Feb 2023

@KevOnTheRanch @LizHighleyman @LauraPowellEsq My comment was RE HPV vaccines. RE bivalent SC2 vaccines which protect against COVID-19: https://t.co/yMOUWaSfiC 🐭

12 Feb 2023

@Hollywood1114 @SilverFire69 @AmestoyKat @ChuckWa15503713 @kylenabecker Check the date, science changes, right? You might want to research a little more. https://t.co/KWBmQ6Oavr

11 Feb 2023

@goneallweek @theJagmeetSingh In this study of immunocompetent persons tested at ICATT locations, bivalent booster doses provided significant additional protection against symptomatic SARS-CoV-2 infection. https://t.co/fDGckNlYJw.

07 Feb 2023

@NoDMsHere Well considering that’s what the evidence shows yep https://t.co/o1F9E8oczM

02 Feb 2023

@P_McCulloughMD @OwenShroyer @DrLoupis @VigilantFox @DrAseemMalhotra @DrKellyVictory @JonnyRoot_ @drcraigwax @12Johnstockton Hmm, guess the peer review at NEJM must be slipping. Well, here is a large analysis of Covid testing data showing that bivalent b

02 Feb 2023

@iacoden @swede_irish @thereal_truther @JaneDoe69086964 https://t.co/Kx8aLaInea

02 Feb 2023

ワクチン回数が多い方が感染しやすい論が統計的に間違っているこの計算でその結論はないのでは？ https://t.co/9cRNOqe5Tc https://t.co/eg9nzj1kIb

01 Feb 2023

ずーっと論文見てますけど　初期は一瞬効いたように見えてましたけど長い目で見た時にきちんと効いたという結論に導かれるものは出ていないと思います。

01 Feb 2023

@b0yakizz ありがとうございます！んー、先生が根拠にあげている情報を読むと、「ワクチンは有効」「2価ワクチンを含め最新のワクチンに更新する必要がある」という結論のようなので、ワクチン打つほど感染しやすいという解釈は恣意的かもですね。 https://t.co/amw1bki56C

01 Feb 2023

@meimei881 日本語の方がいいですよね。こちらをどうぞ。 https://t.co/zPF8vEFf4w 海外ならいくらでもあります。まだ2価ワクチンの大がかりな報告はあまりないですけど。 https://t.co/k4bSIwyiTX https://t.co/mYGpryZmQ9

31 Jan 2023

2 価(起源株/BA.4-5)ワクチン追加接種者において従来型ワクチン接種から 2~3 か月および 8 か月以上経過した者と比較した発症予防に関する有効率は、それぞれ 18~49 歳で 30%と 56%、50~64 歳で 31%と 48%、65 歳以上で 28%と 43%でした。 https://t.co/IZO20W7IzO

31 Jan 2023

@2000_tantantan @MNHR_Labo 五月雨でごめんなさい。こちらはCDCの情報。 https://t.co/k4bSIwyiTX

31 Jan 2023

@noncomplianz @DrSusanOliver1 @BioMedCentral As you know, the evidence is overwhelming, at all ages I’ve never taken a penny from vaccine companies There are too many papers/studies to post, but you’ll enjoy these https://t.co/pWIXUYxHIS https://t.c

30 Jan 2023

@ZacharyLevi People should be free to choose whether they believe the known side effects of the vaccine are a worthy trade on their body for a vaccine that is only 56% effective for ages 18-49 — trust the science & make an informed choice https://t.co/

29 Jan 2023

@blufreezy @DTSB76 @thedotconnectr @Shawncormier08 @Sir_Digby_C_S @Branth777 Covid vaccines still have efficacy. I don't care if you believe it. https://t.co/XR5j07uACA https://t.co/0sDZMjycmW

28 Jan 2023

@jacobcruz123 @SniperFella @CollinRugg Do you know what effectiveness means? https://t.co/2FeoLEaryl. https://t.co/GG2rQwSEx9

@kouma_zaki @TeslaTruckClub @elonmusk @ScottAdamsSays It was much more effective early on with the first variant reducing infection, but the latest booster prevents around 40 to 50% of infections. https://t.co/f26xGoW6p5.

@schrodsc @kouma_zaki @TeslaTruckClub @elonmusk @ScottAdamsSays Early on with the original variant it was as high as 70 to 80%. Even the latest booster can be around 40 to 50%. https://t.co/f26xGoW6p5.

@Max_Fender3 @TeslaTruckClub @elonmusk @ScottAdamsSays The vaccines do a lot. Here are some of the latest results. https://t.co/f26xGoW6p5.

@Coke_Cane_Bear @kouma_zaki @TeslaTruckClub @elonmusk @ScottAdamsSays The original tests weren't for that, but there has been plenty of data since. If you prevent a certain percent of infections, you also prevent those people from being spreaders. https://

@beesykneezi @kouma_zaki @TeslaTruckClub @elonmusk @ScottAdamsSays Yes but there have been many studies since. If you prevent some percentage of infections, by definition you also prevent some of the spread. https://t.co/f26xGoW6p5.

@JMAC_454 @AlastairMcA30 @Ricey709 @ScottAdamsSays It is true though, we know when you are infected with a strain, you are protected primarily from that strain. The same is true for vaccination. https://t.co/Kx8aLaInea

@harald_erler @JimJamLFC @EricTopol @PLOSBiology @Prof_LDHurst @AnneF_S The vaccines were 95% effective at preventing symptomatic infection against the initial strain. They declined to about 60% vs. the same against omicron and its sublineages. The bivalen

24 Jan 2023

@MarcSchaefferGD @matthewherper @Bob_Wachter @HelenBranswell efficacy PEAKED at 20-50% for the bivalent, while BA.5 was still circulating. boosting to prevent infection just isn't going to work. maybe if you get boosted once a month https://t.co/pCJxcJZa0d

23 Jan 2023

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PRE…

23 Jan 2023

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PREVENTED COVID. •https://t.co/RhsS2M2FZj

22 Jan 2023

#ワクチン複数回接種は有害の可能性大感染予防効果ほぼ無し自然免疫生成の邪魔な有害化の可能性大＞Relative vaccine effectiveness dose was 28% and 43% https://t.co/AXntQNOaHU

22 Jan 2023

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

21 Jan 2023

@zimsmom @CDCMMWR @GregoryRSL @_mktaylor @BeckettStephen @joshuasweitz https://t.co/iBJxUufVFr https://t.co/7uuiux1P7D https://t.co/QigiEeuOKp

RT @hfrank6048: @A352427 @tommyboy0690 https://t.co/DeCLpkby5b “bivalent boosters provided significant additional protection against sympt…

RT @hfrank6048: @A352427 @tommyboy0690 https://t.co/DeCLpkby5b “bivalent boosters provided significant additional protection against sympt…

RT @hfrank6048: @A352427 @tommyboy0690 https://t.co/DeCLpkby5b “bivalent boosters provided significant additional protection against sympt…

@NathanSteiner @timmullaney @FLVoiceNews Here's one specifically on the bivalent vaccine. They found it wasn't highly effective, but it was effective, especially if it had been a long time since your last dose. https://t.co/Oc7bCS7baz https://t.co/1MC9sJ

19 Jan 2023

Tam sözünü ettiğiniz türden değerlendirme değil ama yine de anlamlı: This study evaluated aVE and rVE by number of previous monovalent doses received and generally found similar additional benefit of the bivalent vaccine ... https://t.co/TG6irl2HXF

19 Jan 2023

@GovRonDeSantis https://t.co/dYrhj6untG

@GovRonDeSantis Idiots with no scientific expertise need to shut up about vaccines. You need to pay attention to the scientists and medical experts. https://t.co/THcbWEeX8b

@HidingoutinFL @TheBoyConker @DrCanuckMD There has been ONE bivalent vax study since Sept release. You've stated some common hearsay misinfo that's inconsistent w/ the report's findings & CDC's announcements Effectiveness of Bivalent mRNA Vaccines in

RT @carpe_diem0820: 米国での2価ワクチンの有効性報告前回接種からの間隔の長期化で有効性↑ 重症化予防約50% Effectiveness of Bivalent mRNA Vaccines in Preventing COVID-19-Associate…

RT @j_sato: CDCの「武漢株一価💉の効果が落ちているので、オミ株二価💉を接種しよう」と呼びかける資料データから、💉の感染予防効果を算出すると・武漢株💉2回：-26% ・武漢株💉3回：-59% ・武漢株💉4回：-76% となって、💉するほど非接種者より感染しやす…

16 Jan 2023

@TheSadViolin @jumpstart1977 @mountain_ted @healthbyjames Again, let me know if the words are too big for you… https://t.co/81Mt7lA08u

16 Jan 2023

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what that means? Psst…

@uppercasemag @EricTopol @CorsIAQ @NEJM It does stop transmission https://t.co/Drc3MZpwuZ

@joindontdie @coloradobenji It was dumb of you to think that prevents transmission meant 100% of all infections all the time. https://t.co/Drc3MZpwuZ

@BridgetVervain @flarfernutter @joindontdie They prevent transmission, just not 100% https://t.co/Drc3MZpwuZ

@flarfernutter @BridgetVervain @joindontdie They do https://t.co/Drc3MZq4kx

@joindontdie The covid vaccines do prevent transmission. https://t.co/Drc3MZpwuZ

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what that means? Psst…

@bdonedone @chrislhayes The actual data shows the opposite. https://t.co/DBc2PpypIZ (Summary of above) https://t.co/11TNjj7UkI

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR https://t.co/eDxFZDG1cq

@DrPaulOffit so you‘re having an opinion while evidence points in a different direction? how original and smart. not. https://t.co/OHUWBUh2lS

@RaySahelian_MD @VeteranOfBS @jecasey3 @ninaturner https://t.co/1F5srbUnAx

@RepThomasMassie No vaccine is 100% effective. https://t.co/dTktFmTh6M via @CDCgov

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what that means? Psst…

RT @DruvBhagavan: @luckytran Per a CDC MMWR (12/2/22), the bivalent boosters offer an additional *~30-60%* protection against symptomatic i…

12 Jan 2023

@MeetsLight Tässä kyseinen tutkimus. https://t.co/OE9ioKgr7e Ja tässä selitetty englanniksi: https://t.co/xC4V6nBjr4

12 Jan 2023

@FellaFala @MeetsLight Löytyi useita. Katsomatta mm. Israelin data ja @DrEricDing https://t.co/AHvz4yRrY1

12 Jan 2023

RT @nathan_a_tanner: @joshtpm (it is extremely clear that it helps FWIW) https://t.co/Evs24yJrBR

@joshtpm (it is extremely clear that it helps FWIW) https://t.co/Evs24yJrBR

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what that means? Psst…

@AtomsksSanakan @Brkr_Morant @EmilyPetro22 @Covid19Ls @mauveTriforce @zipsmooch @BogusBones208 @LobotomizedM1 @GYamey @InCytometry @MaryanneDemasi @JonathanSarfat1 Emily needs to see this thread:

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what that means? Psst…

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what that means? Psst…

@MeetsLight @Jussi7 Se on tämä toinen tutkimus https://t.co/nEyEt8PSqf

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what that means? Psst…

The bivalent mRNA vaccines prevented symptomatic SARS-CoV-2 infection. PREVENTED! https://t.co/LkhwVUuPPY https://t.co/LkhwVUuPPY

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what that means? Psst. It means they PREVENTED COVID. •https://t.co/RhsS2M3dOR

@MeetsLight Toiset 5 sek käytetty. https://t.co/nEyEt8PSqf

RT @Neoavatara: @KevinWGlass CONCLUSION: No discernable differences in protection against symptomatic BA.1 and BA.2 infection were seen wi…

@KevinWGlass Nobody, including the CDC, is showing 50% efficacy after three months. At 2-3 months? Sure. https://t.co/BKfFTZ0M5f

@KevinWGlass CONCLUSION: No discernable differences in protection against symptomatic BA.1 and BA.2 infection were seen with previous infection, vaccination, and hybrid immunity. There are more studies that show this result...here is another from CDC:

@JLPJLP2k He's 100% wrong. More booster less risk of contacting COVID 19. This has been proven. He's looking at total numbers. Over 90% of the population has now had at least 1 shot. https://t.co/RY3zd8edRx

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means the vacc…

RT @BOOSTICStudy: Interesting study from the @CDCgov on vaccine efficacy of bivalent mRNA COVID vaccines https://t.co/bDS5XqkIP4.

RT @BOOSTICStudy: Interesting study from the @CDCgov on vaccine efficacy of bivalent mRNA COVID vaccines https://t.co/bDS5XqkIP4.

Interesting study from the @CDCgov on vaccine efficacy of bivalent mRNA COVID vaccines https://t.co/bDS5XqkIP4.

@M_Alazon @UltimeBouts @france_soir CDC Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 https://t.co/ObEVu7H3n0

RT @DruvBhagavan: @luckytran Per a CDC MMWR (12/2/22), the bivalent boosters offer an additional *~30-60%* protection against symptomatic i…

@luckytran Per a CDC MMWR (12/2/22), the bivalent boosters offer an additional *~30-60%* protection against symptomatic infection over ≥2 monovalent only doses (rVE). Efficacy increases with time since last monovalent dose (as one might expect, given ↓ NA

@21BlackHearts @StanCat10338832 @MattWallace888 I’m a “medical professional”. I’ve been a nurse for over 40 years. I’m fully vaccinated (5 vaccines) and I believe they help mitigate symptoms but they do NOTHING for prevention. Even the CDC states this yet

RT @kakeashi_ashika: BA.5用ブースターによる中和活性評価が出揃ったところで過ぎ去りしBA.5の波に対する効果をみていく。まずは感染防止の観点から。2022年11月22日に出たCDCのMMWR。2/3/4dosesは事前の武漢型用の接種回数だが、回数を…

RT @kakeashi_ashika: BA.5用ブースターによる中和活性評価が出揃ったところで過ぎ去りしBA.5の波に対する効果をみていく。まずは感染防止の観点から。2022年11月22日に出たCDCのMMWR。2/3/4dosesは事前の武漢型用の接種回数だが、回数を…

RT @kakeashi_ashika: BA.5用ブースターによる中和活性評価が出揃ったところで過ぎ去りしBA.5の波に対する効果をみていく。まずは感染防止の観点から。2022年11月22日に出たCDCのMMWR。2/3/4dosesは事前の武漢型用の接種回数だが、回数を…

RT @kakeashi_ashika: BA.5用ブースターによる中和活性評価が出揃ったところで過ぎ去りしBA.5の波に対する効果をみていく。まずは感染防止の観点から。2022年11月22日に出たCDCのMMWR。2/3/4dosesは事前の武漢型用の接種回数だが、回数を…

BA.5用ブースターによる中和活性評価が出揃ったところで過ぎ去りしBA.5の波に対する効果をみていく。まずは感染防止の観点から。2022年11月22日に出たCDCのMMWR。2/3/4dosesは事前の武漢型用の接種回数だが、回数を重ねるとむしろ逆効果？！BA.5用の有症状感染防止効果は50歳未満で4割、以上で2割。

@Elle_Ham06 @tedtalksoph @Otto_English @d415y4g3 "All persons should stay up to date with recommended COVID-19 vaccines, including bivalent booster doses, if it has been ≥2 months since their last monovalent vaccine dose (1)." https://t.co/XzZwVpZOMj

07 Jan 2023

@DrTomFrieden why do so many believe "there has not been testing of bivalent vaccine effectiveness?" (or the claim "only 8 people tested?") The data is widely available, This is study of 360,000. I think CDC has a hard time competing with internet rumors.

07 Jan 2023

@MozarkMike @DrTomFrieden 360,000 tests in the study, show bivalent is effective at reducing risk of severe CV. https://t.co/93VSnaSc1K.

07 Jan 2023